NUVLNuvalent Inc - Ordinary Shares - Class A
NUVL
Nuvalent Inc - Ordinary Shares - Class A444
Mkt Cap
$8.04BVolume
28,408.0052W High
$113.0252W Low
$55.54PE Ratio
-17.48NUVL Fundamentals
Price
$103.93Prev Close
$102.25Open
$106.0350D MA
$101.42Beta
1.15Avg. Volume
566,676.43EPS (Annual)
-$5.85P/B
6.41Rev/Employee
$0.00$5,939.61
Nuvalent's (NUVL) Outperform Rating Reaffirmed at Wedbush
Wedbush reiterated an "outperform" rating and issued a $125.00 price target on shares of Nuvalent in a report on Wednesday...
MarketBeat·1h ago
Nuvalent Announces NDA Submission For Neladalkib
(RTTNews) - Nuvalent, Inc. (NUVL) announced the submission to the FDA of the company's NDA for neladalkib, an investigational ALK-selective inhibitor, in TKI pre-treated advanced ALK-positive NSCLC. The application is based on data in TKI pre-treated patients with advanced ALK-po...
Nasdaq News: Markets·1d ago
Nuvalent Announces Submission of New Drug Application to FDA for Neladalkib in TKI Pre-treated Advanced ALK-positive NSCLC
Nuvalent Announces Submission of New Drug Application to FDA for Neladalkib in TKI Pre-treated Advanced ALK-positive NSCLC Nuvalent Announces Submission of New Drug Application to FDA for Neladalkib...
PR Newswire·1d ago
Aberdeen Group plc Increases Holdings in Nuvalent, Inc. $NUVL
Aberdeen Group plc raised its position in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 115.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·1d ago
Nuvalent (NASDAQ:NUVL) CFO Alexandra Balcom Sells 11,430 Shares
Nuvalent, Inc. (NASDAQ:NUVL - Get Free Report) CFO Alexandra Balcom sold 11,430 shares of the business's stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of...
MarketBeat·5d ago
Nuvalent (NASDAQ:NUVL) Earns Overweight Rating from Analysts at Wells Fargo & Company
Wells Fargo & Company initiated coverage on shares of Nuvalent in a research report on Monday. They issued an "overweight" rating and a $116.00 target price for the company...
MarketBeat·9d ago
Hudson Bay Capital Management LP Purchases New Stake in Nuvalent, Inc. $NUVL
Hudson Bay Capital Management LP acquired a new position in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 15,000 shares of the company's stock...
MarketBeat·16d ago
Cantor Fitzgerald L. P. Makes New $1.95 Million Investment in Nuvalent, Inc. $NUVL
Cantor Fitzgerald L. P. bought a new position in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 22,500 shares of the company's stock, valued a...
MarketBeat·20d ago
Nuvalent to Present New Preclinical and Clinical Data for Zidesamtinib, an Investigational ROS1-Selective Inhibitor, at AACR Annual Meeting 2026
Nuvalent to Present New Preclinical and Clinical Data for Zidesamtinib, an Investigational ROS1-Selective Inhibitor, at AACR Annual Meeting 2026 Nuvalent to Present New Preclinical and Clinical Data...
PR Newswire·22d ago
Nuvalent, Inc. (NASDAQ:NUVL) Given Average Rating of "Moderate Buy" by Analysts
Nuvalent, Inc. (NASDAQ:NUVL - Get Free Report) has earned an average recommendation of "Moderate Buy" from the sixteen research firms that are presently covering the company, Marketbeat.com reports...
MarketBeat·22d ago
<
1
2
...
>